Results 21 to 30 of about 4,171 (150)

Impact of Chronic Kidney Disease Severity on the Risk of Prurigo Nodularis: A Population-Based Cohort Study

open access: yesActa Dermato-Venereologica, 2022
While dialysis is linked with prurigo nodularis, little is known about the impact of non-dialysis chronic kidney disease on prurigo nodularis. The influence of chronic kidney disease on development of prurigo nodularis was measured using the Korean ...
Hyeong Sik Ahn, Hei Sung Kim
exaly   +3 more sources

Chronic Nodular Prurigo: A European Cross-Sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction

open access: yesActa Dermato-Venereologica, 2021
Chronic nodular prurigo is characterized by recalcitrant itch. Patient perspectives on therapeutic goals, satisfaction with therapy and efficacy of therapeutic regimens for this condition are unknown. This questionnaire study examined these issues in 406
Manuel Pedro Pereira   +2 more
exaly   +2 more sources

Analysis of 325 Patients With Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment

open access: yesActa Dermato-Venereologica, 2020
Chronic nodular prurigo presents with multiple pruriginous nodules and severe pruritus. This study aims to explore the treatment course and regimens in patients with chronic nodular prurigo and to analyse predictive factors contributing to therapeutic ...
Gudrun Schneider   +2 more
exaly   +2 more sources

[Translated article] Update on Chronic Prurigo

open access: yesActas Dermo-Sifiliográficas, 2022
Chronic prurigo is itself a common condition, but it can also occur secondary to a large number of diseases. Management is challenging as historically chronic prurigo has been poorly defined and very few treatments are available.
A. Docampo-Simón   +2 more
doaj   +2 more sources

Chronic Prurigo of Nodular Type: A Review

open access: yesActa Dermato-Venereologica, 2017
Prurigo nodularis (PN) is a subtype of chronic prurigo presenting single to multiple symmetrically distributed, hyperkeratotic and intensively itching papules and nodules.
Claudia Zeidler   +5 more
doaj   +4 more sources

Chronic prurigo in an adolescent patient successfully controlled with dupilumab [PDF]

open access: yesSkin Health and Disease
Abstract Chronic prurigo, formerly termed prurigo nodularis, is a chronic skin condition characterized by intensely itchy nodules and papules. It primarily affects adults, particularly middle-aged women. The aetiology of chronic prurigo is unclear, but it can be associated with primary skin dermatoses and systemic conditions.
Mohammed Nasser Al-Abdulla   +6 more
openaire   +4 more sources

TRPM8 Agonist (Cryosim-1) Cream for Chronic Prurigo: A Randomized, Vehicle-controlled Trial [PDF]

open access: yesActa Dermato-Venereologica
Chronic prurigo (CP) is a distressing dermatological condition lacking effective topical therapies. This randomized, double-blind, vehicle-controlled trial evaluated the efficacy and safety of Cryosim-1, a TRPM8 agonist cream, in 30 adults with CP ...
Ji Young Um   +5 more
doaj   +2 more sources

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel [PDF]

open access: yesDermatology and Therapy
Objective Chronic prurigo (CPG) is a chronic neuroinflammatory skin disease characterized by persistent itch, repeated scratching, and the presence of multiple skin lesions.
Pedro Mendes-Bastos   +5 more
doaj   +2 more sources

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2023
Shinji Mitsuyama, Tetsuya Higuchi
doaj   +2 more sources

Standardizing Prurigo Control Assessment Globally: Linguistic Validation and Cross-cultural Adaptation of Prurigo Control Test in 18 Languages [PDF]

open access: yesActa Dermato-Venereologica
Chronic prurigo (CPG), including prurigo nodularis (PN), is a neuroimmune-inflammatory skin condition characterized by persistent itching and fibrotic lesions.
Martin Metz   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy